News | July 23, 2010

Point-of-Care Analyzer May Speed ER Cardiac Evaluations

July 23, 2010 – For patients suffering from a heart attack, every minute counts, yet the average time from start of chest pain to receiving emergency room (ER) medical attention is 3.2 hours. The average turn-around time of lab-based test results is 2.8 hours, with the minimum time to detect a heart attack using today’s lab-based immunodiagnostics is 4.5 hours from symptom outset.

When it comes to cardiac events and survival, the key factors for a successful recovery are time to diagnosis, accuracy of diagnosis, and appropriate clinical management. For these reasons point-of-care (POC) testing for chest pain patients may help improve patient survival.

Ontario-based CardioGenics has created improved cardiac diagnostic testing that boasts faster results, better accuracy, at reduced cost to the patient and caregiver. The analyzer offers advantages over existing POC immunoassay technology, which the company compares to the shift from portable CD players to iPods. In six steps, the QL Care Analyzer provides printed medical lab quality results in less than 15 minutes. Capable of delivering test results in the ER, doctor’s office, or EMS vehicle, the single-use cartridge QL Care Analyzer is the size of a portable CD player, features an intuitive user interface touch screen, and is capable of storing patient data for up to 5,000 individuals.

The QL Care Analyzer is being submitted to the U.S. Food and Drug Administration (FDA) this summer for testing of troponin I, a protein that is integral to cardiac muscle and its blood level measures the presence and severity of a heart attack.

CardioGenics believes that the device cartridge can ultimately be adapted to run any number of immunoassay tests. (There are approximately 200 different immunoassays for HIV, cancer, thyroid conditions, etc., that are currently performed by lab-based analyzers).

For more information: www.cardiogenics.com

Related Content

AUM Cardiovascular Receives FDA Approval for CADence ECG Device
Technology | ECG| August 08, 2017
AUM Cardiovascular announced it has received clearance from the U.S. Food and Drug Administration (FDA) for CADence, a...
New Jersey Researcher Exploring New Stem Cell Therapies for Heart Attacks
News | Stem Cell Therapies| August 04, 2017
In petri dishes in her campus laboratory at New Jersey Institute of Technology, Alice Lee is developing colonies of...
New Study Focuses on Protein Responsible For Increased Heart Disease Risk
News | Cardiac Diagnostics| August 03, 2017
August 3, 2017 — A study to reduce the strongest inherited...
Left Atrial Pressure Monitor from Vectorious Medical Technologies Offers New Hope for Heart Failure Patients

On of the top stories in July was the introduction of a left atrial pressure monitor from Vectorious Medical Technologies to prevent heart failure patient hospitalizations or readmissions. Read the article"Left Atrial Pressure Monitor Offers New Hope for Heart Failure Patients."

Feature | August 01, 2017 | Dave Fornell
Aug.
Philips released a new version of its iFR system that displays FFR readings as an overlay on live angiographic, angiogram images.

Philips released a new version of its iFR system that displays hemodynamic pressure drop points in an overlay on live angiographic images, matching up the iFR readings with corresponding lesions. The system is supposed to speed diagnostic decision making and help guide percutaneous revascularization procedures. 

Feature | FFR Catheters| July 31, 2017 | Dave Fornell
The gold standard for assessing the hemodynamic significance or coronary lesions to determine if they should be revas
Siemens Healthineers to Acquire Epocal from Alere
News | Point of Care Testing| July 26, 2017
Siemens Healthineers has entered into a definitive agreement to acquire Epocal Inc., a subsidiary of Alere Inc. Epocal...
New PET-CT Scan Improves Detection in Rare Cardiac Condition
News | PET-CT| July 25, 2017
Using a new imaging technique that can diagnose cardiac sarcoidosis much more accurately than traditional tests,...
3-D Vascular Ultrasound Quantifies Plaque Burden to Estimate Cardiovascular Risk
News | Cardiovascular Ultrasound| July 20, 2017
July 20, 2017 — In a large, first-of-its-kind population, researchers found an experimental technique known as...
More Than 20 Percent of Low-Risk Patients Receive Annual ECG
News | ECG| July 20, 2017
July 20, 2017 — More than one in five Ontario patients receive an ...
Alere point of care POC testing for INR
News | Point of Care Testing| July 17, 2017 | Dave Fornell
July 17, 2017 — Despite issues with point-of-care INR testing company Alere Inc., Abbott announced this week it is on
Overlay Init